Latest Breaking News On - University ontario - Page 11 : comparemela.com

CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health ) , an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine®, which has demonstrated at least 10-times (10X) the efficacy compared to Pharma Grade CBD. Mentanine® - an International CBD Excellence Award 2020 formulation was scientifically developed through preclinical trials at Western University. Results of its potential effect on anxiety, depression, PTSD, and schizophrenia have been statistically significant. Our evidence also found that this formulation targeted a specific nuclear cellular receptor involved in anti-inflammatory mechanisms indicating that this formula may also treat inflammatory disorders.

United statesSteven lavioletteKostenloser wertpapierhandelRob rindermanPaul ramsayInternational patentCompany or canaquestBiomedical corpSecurities exchangeCanaquest coHealth canadaCanaquest medical corpUniversity ontarioPharma gradeWestern universityCentral nervous system